PSYCHEMEDICS CORPORATION CMN - COM (PMD)

CUSIP: 744375205

Q1 2019 13F Holders as of 31 Mar 2019

Type / Class
Equity / COM
Total 13F shares
3,174,281
Share change
+62,614
Total reported value
$44,544,609
Price per share
$14.03
Number of holders
48
Value change
+$813,365
Number of buys
16
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 744375205?
CUSIP 744375205 identifies PMD - PSYCHEMEDICS CORPORATION CMN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PSYCHEMEDICS CORPORATION CMN - COM (PMD) as of Q1 2019

As of 31 Mar 2019, PSYCHEMEDICS CORPORATION CMN - COM (PMD) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,174,281 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, CRAWFORD INVESTMENT COUNSEL INC, Tieton Capital Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, DEPRINCE RACE & ZOLLO INC, KENNEDY CAPITAL MANAGEMENT, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, Uniplan Investment Counsel, Inc., and BLAIR WILLIAM & CO/IL. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.